ICER’s ‘Unsupported Price Increase’ Report Due This Fall

Report by the Institute for Clinical and Economic Review will seek to inform the public policy debate on price increases for prescription drugs.

PS1807_Pills Under Scrutiny_141058420_1200.jpg

The Institute for Clinical and Economic Review plans to issue a first annual report in early October examining whether large price increases for select prescription drugs are supported by new clinical evidence.

The group released a draft protocol of the process it will use to develop the report on Jan. 17 with...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Pricing Debate

More from Market Access